LLY

934

+3.03%↑

JNJ

186.56

-0.2%↓

UNH

327.16

-0.95%↓

NVS

125.6

+0.39%↑

ABT

124.77

-0.56%↓

LLY

934

+3.03%↑

JNJ

186.56

-0.2%↓

UNH

327.16

-0.95%↓

NVS

125.6

+0.39%↑

ABT

124.77

-0.56%↓

LLY

934

+3.03%↑

JNJ

186.56

-0.2%↓

UNH

327.16

-0.95%↓

NVS

125.6

+0.39%↑

ABT

124.77

-0.56%↓

LLY

934

+3.03%↑

JNJ

186.56

-0.2%↓

UNH

327.16

-0.95%↓

NVS

125.6

+0.39%↑

ABT

124.77

-0.56%↓

LLY

934

+3.03%↑

JNJ

186.56

-0.2%↓

UNH

327.16

-0.95%↓

NVS

125.6

+0.39%↑

ABT

124.77

-0.56%↓

Search

AmerisourceBergen Corporation

Abierto

SectorSalud

0

Resumen

Variación precio

24h

Actual

Mínimo

Máximo

Métricas clave

By Trading Economics

Ingresos

-28M

690M

Ventas

5.2B

81B

P/B

Media del Sector

34.967

77.256

BPA

4

Rentabilidad por dividendo

0.64

Margen de beneficio

0.855

Empleados

51,000

EBITDA

-56M

1.3B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+1.13% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.64%

2.33%

Próximas Ganancias

5 nov 2025

Fecha Próximo Dividendo

28 nov 2025

Próxima Fecha de Ex Dividendo

14 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

9.2B

66B

Apertura anterior

0

Cierre anterior

0

Noticias sobre sentimiento de mercado

By Acuity

45%

55%

143 / 373 Clasificación en Healthcare

AmerisourceBergen Corporation Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

4 nov 2025, 23:57 UTC

Ganancias

Naver's Third-Quarter Earnings Rose on AI Push

4 nov 2025, 23:10 UTC

Adquisiciones, fusiones, absorciones

Kennedy-Wilson Gets Acquisition Proposal From CEO, Fairfax Financial

4 nov 2025, 23:48 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 nov 2025, 23:48 UTC

Charlas de Mercado

Nikkei May Fall After U.S. Tech Stock Weakness -- Market Talk

4 nov 2025, 23:37 UTC

Charlas de Mercado

Gold Edges Higher on Possible Technical Recovery -- Market Talk

4 nov 2025, 23:30 UTC

Ganancias

Itau Unibanco 3Q Net BRL33.7B >ITUB

4 nov 2025, 23:25 UTC

Ganancias

Naver 3Q Net Profit Beat FactSet-Compiled Consensus

4 nov 2025, 23:25 UTC

Ganancias

Naver 3Q Net KRW734.70B Vs. Net KRW530.10B >035420.SE

4 nov 2025, 23:24 UTC

Ganancias

Naver 3Q Oper Pft KRW570.60B Vs. Pft KRW525.30B >035420.SE

4 nov 2025, 23:23 UTC

Ganancias

Naver 3Q Rev KRW3.138T Vs. KRW2.716T >035420.SE

4 nov 2025, 23:06 UTC

Ganancias

Review & Preview: Tech Check -- Barrons.com

4 nov 2025, 22:52 UTC

Ganancias

AMD Reports Sharply Higher Profits, Sales -- 3rd Update

4 nov 2025, 22:33 UTC

Ganancias

AMD Beats Earnings. The Stock Still Slides. -- Barrons.com

4 nov 2025, 22:29 UTC

Ganancias

Ashland 4Q Adj EPS $1.08 >ASH

4 nov 2025, 22:29 UTC

Ganancias

Ashland Sees FY26 Adjusted EPS Up More Than Double Digits >ASH

4 nov 2025, 22:28 UTC

Ganancias

Ashland Sees FY26 Sales $1.84B-$1.91B >ASH

4 nov 2025, 22:27 UTC

Ganancias

Ashland 4Q Cont Ops EPS 73c >ASH

4 nov 2025, 22:27 UTC

Ganancias

Ashland 4Q EPS 71c >ASH

4 nov 2025, 22:27 UTC

Ganancias

Ashland 4Q Sales $478M >ASH

4 nov 2025, 22:23 UTC

Ganancias

Ovintiv 3Q EPS 57c >OVV

4 nov 2025, 22:19 UTC

Charlas de Mercado

Canada Budget: Snap Election Talk Might Cool -- Market Talk

4 nov 2025, 22:16 UTC

Ganancias

AMD Reports Sharply Higher Profits, Sales -- 2nd Update

4 nov 2025, 22:14 UTC

Adquisiciones, fusiones, absorciones

Kennedy-Wilson Board Forms Special Committee to Evaluate Proposal

4 nov 2025, 22:13 UTC

Adquisiciones, fusiones, absorciones

Consortium: Not Interested in Selling Kennedy-Wilson Shares to Another Party

4 nov 2025, 22:13 UTC

Adquisiciones, fusiones, absorciones

Consortium: Able to Finance a Deal With Available Liquidity

4 nov 2025, 22:12 UTC

Adquisiciones, fusiones, absorciones

Consortium Owns About 31% of Kennedy-Wilson Stock on As-Converted Basis

4 nov 2025, 22:11 UTC

Ganancias

Private-Credit Earnings Ease Investor Concern Over Market's Health -- Update

4 nov 2025, 22:11 UTC

Adquisiciones, fusiones, absorciones

Kennedy-Wilson Gets Proposal From CEO William McMorrow and Fairfax Financial Holdings

4 nov 2025, 22:10 UTC

Adquisiciones, fusiones, absorciones

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup -- 2nd Update

4 nov 2025, 22:07 UTC

Ganancias

Kinross Gold Raises Dividend to $0.035 >K.T

Comparación entre iguales

Cambio de precio

AmerisourceBergen Corporation Esperado

Precio Objetivo

By TipRanks

1.13% repunte

Estimación a 12 meses

Media 348.44 USD  1.13%

Máximo 380 USD

Mínimo 322 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para AmerisourceBergen Corporation Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

9 ratings

8

Comprar

1

Mantener

0

Vender

Sentimiento

By Acuity

143 / 373 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de AmerisourceBergen Corporation

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat